A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)

Nandita Chaturvedi; Rebekah Arias; Dandan Tu; Samuel Mabbott; Gerard L. Coté

doi:10.1117/12.2607695

2 March 2022 A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)

Nandita Chaturvedi, Rebekah Arias, Dandan Tu, Samuel Mabbott, Gerard L. Coté

Author Affiliations +

Proceedings Volume 11968, Optical Diagnostics and Sensing XXII: Toward Point-of-Care Diagnostics; 1196805 (2022) https://doi.org/10.1117/12.2607695
Event: SPIE BiOS, 2022, San Francisco, California, United States

Abstract

Today, approximately 5 million Americans are living with Congestive Heart Failure (CHF), and this burden is higher for African American communities, even for control groups. Implantable devices to measure pulmonary artery pressure are sometimes indicated as a surrogate measure for fluid retention in the lungs caused by worsening heart failure but are often inaccessible to underserved communities due to the prohibitive costs of the device and surgical procedure. Thus, we are implementing a sensitive immunoassay on a low-cost paper fluidic platform, to enable the frequent and easy measurements of B-type Natriuretic Peptide (BNP), an important biomarker secreted by cardiomyocytes in response to the increasing ventricular stretch and cardiac volume. BNP concentrations are often used to classify CHF into 4 levels of severity on the New York Heart Association (NYHA) scale. The paper fluidic cartridge is composed of thin, economical cotton, glass fiber and nitrocellulose membranes, that are modified to improve the flow of the sample volume. We incorporate a sandwich assay using surface-enhanced Raman scattering (SERS)-active gold nanoparticles for signal transduction, a BNP-specific aptamer for detection as well as stabilization of the nanoparticle conjugate, and a monoclonal antibody specific to BNP for the recognition element, onto this cartridge. By using a handheld Raman reader with a 638 nm excitation laser, we retrieve SERRS spectra for the malachite green isothiocyanate dye which corresponds to BNP capture ranging from 0.3 ng/mL (Stage II) to 1 ng/mL (Stage IV). We also show the visual, colorimetric detection of these concentrations using the RGB pixels from the test line, demonstrating the potential for a multi-modal approach for this diagnostic test.

Conference Presentation

Citation Download Citation

Nandita Chaturvedi, Rebekah Arias, Dandan Tu, Samuel Mabbott, and Gerard L. Coté "A low-cost, paper fluidic platform to detect B-type Natriuretic Peptide (BNP) for Congestive Heart Failure (CHF)", Proc. SPIE 11968, Optical Diagnostics and Sensing XXII: Toward Point-of-Care Diagnostics, 1196805 (2 March 2022); https://doi.org/10.1117/12.2607695

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available